The Collaborative Drug Discovery (CDD) database.

The broad goals of Collaborative Drug Discovery (CDD) are to enable a collaborative "cloud-based" tool to be used to bring together neglected disease researchers and other researchers from usually separate areas, to collaborate and to share compounds and drug discovery data in the research community, which will ultimately result in long-term improvements in the research enterprise and health care delivery. This chapter briefly introduces CDD software and describes applications in antimalarial and tuberculosis research.

[1]  Jeffrey R. Huth,et al.  Enhancement of chemical rules for predicting compound reactivity towards protein thiol groups , 2007, J. Comput. Aided Mol. Des..

[2]  Ying Zhang,et al.  The magic bullets and tuberculosis drug targets. , 2005, Annual review of pharmacology and toxicology.

[3]  Antony J Williams,et al.  Internet-based tools for communication and collaboration in chemistry. , 2008, Drug discovery today.

[4]  Sean Ekins,et al.  When pharmaceutical companies publish large datasets: an abundance of riches or fool's gold? , 2010, Drug discovery today.

[5]  Sean Ekins,et al.  Competitive collaboration in the pharmaceutical and biotechnology industry. , 2009, Drug discovery today.

[6]  Renaldo Mendoza,et al.  ALARM NMR: a rapid and robust experimental method to detect reactive false positives in biochemical screens. , 2005, Journal of the American Chemical Society.

[7]  Tudor I. Oprea.  Current trends in lead discovery: Are we looking for the appropriate properties? , 2002, J. Comput. Aided Mol. Des..

[8]  C. Tralau-Stewart,et al.  Drug discovery: new models for industry-academic partnerships. , 2009, Drug discovery today.

[9]  Sean Ekins,et al.  Analysis and hit filtering of a very large library of compounds screened against Mycobacterium tuberculosis. , 2010, Molecular bioSystems.

[10]  Lynn Rasmussen,et al.  Antituberculosis activity of the molecular libraries screening center network library. , 2009, Tuberculosis.

[11]  Sean Ekins,et al.  Validating New Tuberculosis Computational Models with Public Whole Cell Screening Aerobic Activity Datasets , 2011, Pharmaceutical Research.

[12]  Anang A. Shelat,et al.  Chemical genetics of Plasmodium falciparum , 2010, Nature.

[13]  Solomon Nwaka,et al.  Science & society: Virtual drug discovery and development for neglected diseases through public–private partnerships , 2003, Nature Reviews Drug Discovery.

[14]  Bernard H. Munos,et al.  Can open-source R&D reinvigorate drug research? , 2006, Nature Reviews Drug Discovery.

[15]  Pedro M Alzari,et al.  Rising standards for tuberculosis drug development. , 2008, Trends in pharmacological sciences.

[16]  Lynn Rasmussen,et al.  High-throughput screening for inhibitors of Mycobacterium tuberculosis H37Rv. , 2009, Tuberculosis.

[17]  Sean Ekins,et al.  Reaching Out to Collaborators: Crowdsourcing for Pharmaceutical Research , 2010, Pharmaceutical Research.

[18]  Peter Ertl,et al.  Designing drugs on the internet? Free web tools and services supporting medicinal chemistry. , 2007, Current topics in medicinal chemistry.

[19]  Sean Ekins,et al.  Meta-analysis of molecular property patterns and filtering of public datasets of antimalarial “hits” and drugs , 2010 .

[20]  Sean Ekins,et al.  Molecular characterization of CYP2B6 substrates. , 2008, Current drug metabolism.

[21]  D. Pompliano,et al.  Drugs for bad bugs: confronting the challenges of antibacterial discovery , 2007, Nature Reviews Drug Discovery.

[22]  Tudor I. Oprea,et al.  Novel chemical space exploration via natural products. , 2009, Journal of medicinal chemistry.

[23]  A J M Carpy,et al.  Structural e-bioinformatics and drug design , 2006, SAR and QSAR in environmental research.

[24]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .

[25]  Antony J. Williams,et al.  Free online resources enabling crowd-sourced drug discovery , 2009 .

[26]  Sean Ekins,et al.  A collaborative database and computational models for tuberculosis drug discovery. , 2010, Molecular bioSystems.

[27]  James R. Brown,et al.  Thousands of chemical starting points for antimalarial lead identification , 2010, Nature.

[28]  Sean Ekins,et al.  Computational Discovery of Novel Low Micromolar Human Pregnane X Receptor Antagonists , 2008, Molecular Pharmacology.

[29]  Sean Ekins,et al.  Novel web-based tools combining chemistry informatics, biology and social networks for drug discovery. , 2009, Drug discovery today.

[30]  Tudor I. Oprea,et al.  Is There a Difference between Leads and Drugs? A Historical Perspective , 2001, J. Chem. Inf. Comput. Sci..

[31]  Antony J. Williams,et al.  A perspective of publicly accessible/open-access chemistry databases. , 2008, Drug discovery today.